SEQURNA®
Download Product Folder
SEQURNA® Thermostable RNase Inhibitor
Synthetic thermostable RNase inhibitor ideal for single-cell and in situ RNA sequencing
SEQURNA Thermostable RNase Inhibitor is a fully synthetic and heat-tolerant inhibitor that protects RNA integrity.
SEQURNA Thermostable RNase Inhibitor is supplied as a solution in vials of 150 or 3 x 150 μl, with a concentration of 50 mass units/μl.
Why SEQURNA® Thermostable RNase Inhibitor?
- Thermostable RNase inhibitor – active across a wide temperature range
- Robust synthetic RNase inhibitor
- Requires no DTT or other toxic reducing agents
- Can easily be stored at room temperature
- Minimizes batch effects in RNase inhibition
Available Products
SEQURNA® Thermostable RNase Inhibitor 150 ul (50 mass units/ul)
Synthetic thermostable RNase inhibitor ideal for single-cell and in situ RNA sequencing.
SEQURNA® Thermostable RNase Inhibitor 3 x 150 ul (50 mass units/ul)
Synthetic thermostable RNase inhibitor ideal for single-cell and in situ RNA sequencing.
For information on how to order, visit Place an Order or contact us directly at order@genovis.com.
Product Information
Unit Defintion
One unit SEQURNA Thermostable RNase Inhibitor is defined as a mass unit, corresponding to the mass per volume of its active components.
Content and Storage
SEQURNA Thermostable RNase Inhibitor is supplied as an aqueous solution with a concentration of 50 mass units/ul. The product is shipped at ambient temperature, and should be stored at room temperature (15-30°C) upon arrival. It also tolerates deep freezing.
Resources
Instruction for Use
Product Specifications
Safety Data Sheet
Certificate of Analysis
Find your certificate of analysis »Noble et al. (2024)
Download Published Article
FLASH-Seq Protocol
Download Detailed Protocol
Smart-seq2 Protocol
Download Detailed Protocol
Smart-seq3 Protocol
Download Detailed Protocol
Smart-seq3xpress Protocol
Download Detailed Protocol
Applications
Synthetic RNase inhibition maintains Smart‑seq2 cDNA yield and quality comparable to protein-based RRIs while decreasing primer‑dimer formation.
Inhibition by synthetic RNase inhibitor (SEQURNA) matches or surpasses recombinant inhibitors in Smart‑seq2 and Smart-seq3 library preparation, including RNase‑rich tissues.
Legal & Disclaimers
All rights reserved. Genovis products may be covered by one or more patents, trademarks and copyrights owned by Genovis AB or licensed from third parties. For more information about commercial rights, please contact the Genovis team at licensing@genovis.com.
Genovis products are intended for research use only. They are not intended to be used for therapeutic or diagnostic purposes in humans or animals. All goods and services are sold subject to Genovis’ General Terms and Conditions of Sale.
© Genovis AB